Search - tctmd.com

Displaying 561 - 580 of 641

Sort: Relevancy | Date

Presentation PCI Outcomes 2012

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Presenter: Gregg W. Stone

March 23, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

News Daily News

Renowned Interventionalist Geoffrey O. Hartzler Dies at Age 65

March 15, 2012

News Daily News

El Renonbrado Intervencionista Geoffrey O. Hartzler Fallece a los 65 Años

March 15, 2012

News Daily News

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

March 07, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Daily News

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

March 07, 2012

News Daily News

HORIZONS-AMI: Las PCI mediante Acceso Radial Reducen las Hemorragias y los MACE en los STEMI

March 07, 2012

News Daily News

Estudio ASCERT: La Supervivencia a Largo Plazo Parece Favorecer al CABG Frente a la PCI contra la Enfermedad Multivaso

L.A. McKeown

March 07, 2012

News Daily News

ASCERT: Long-term Survival Appears to Favor CABG Over PCI for Multivessel Disease

L.A. McKeown

March 07, 2012

Presentation

New Drug-eluting Stent Designs: Are Improved Clinical Outcomes Possible?

Presenter: Gregg W. Stone

March 06, 2012

News Daily News

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

March 05, 2012

News Daily News

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

March 05, 2012

Presentation CTO 2012

The Spectrum of Two-Stent Techniques (and How to Choose)

Presenter: Gregg Stone

February 22, 2012

News Daily News

New Revascularization Appropriateness Criteria Feature PCI Upgrades

January 31, 2012

Presentation ISET 2012

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Presenter: Gregg W. Stone

January 15, 2012

Presentation ISET 2012

The Future of Plaque Differentiation: Stable versus Unstable

Presenter: Gregg W. Stone

January 15, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Vicken Aharonian, Prakash Mansukhani, Gregg W. Stone, Naing Moore, Ric Hyett, Richard Contreras, Somjot S. Brar

January 03, 2012

Advertisement

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Renowned Interventionalist Geoffrey O. Hartzler Dies at Age 65

El Renonbrado Intervencionista Geoffrey O. Hartzler Fallece a los 65 Años

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

HORIZONS-AMI: Las PCI mediante Acceso Radial Reducen las Hemorragias y los MACE en los STEMI

Estudio ASCERT: La Supervivencia a Largo Plazo Parece Favorecer al CABG Frente a la PCI contra la Enfermedad Multivaso

ASCERT: Long-term Survival Appears to Favor CABG Over PCI for Multivessel Disease

New Drug-eluting Stent Designs: Are Improved Clinical Outcomes Possible?

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

The Spectrum of Two-Stent Techniques (and How to Choose)

New Revascularization Appropriateness Criteria Feature PCI Upgrades

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

The Future of Plaque Differentiation: Stable versus Unstable

SCAAR: Second-Generation DES Improve Hard Outcomes

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content